Molecular inhibitor of liver cancer cells
M: Medicine – Surgery – Orthopaedics – Material for disabled
Informations
- Stand number
- E47
- Exhibition class
- M: Medicine – Surgery – Orthopaedics – Material for disabled
- Technical description
- Synthetic inhibitor of human carcinoma HepG2 liver cancer cells that may find application in medicine. This agent exeeds 4 times the analogous characterstics of the prototype that is used in medical practice
- Simplified description
- A new synthetic drug has shown great promise in fighting HepG2 liver cancer cells, performing four times better than the current treatment used in medical practice. This breakthrough could lead to advancements in cancer treatment.
Inventors
Donald POIRIER
inventor 3701094179_4403
Victor Tapcov
inventor 3701094179_4402
Dorin ISTRATI
inventor 3701094179_4401
Aurelian GULEA
inventor 3701094179_4400
Information in this online catalogue is based on data received for the Event and updated by the participant. Catalogue entries remain the sole responsability of the participant. The Exhibition management declines all responsibility for any possible errors or omissions.